Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natsuko Watanabe

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Thyroid : Official Journal of the American Thyroid Association|October 2, 2019
Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in JapanNami Suzuki, Jaeduk Yoshimura Noh, Marino Hiruma, et al.
Thyroid : Official Journal of the American Thyroid Association|November 15, 2018
Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine TherapyAi Yoshihara, Kenji Iwaku, Jaeduk Yoshimura Noh, et al.
Endocrine Journal|April 9, 2013
Determination of pediatric reference levels of FT3, FT4 and TSH measured with ECLusys kitsKenji Iwaku, Jaeduk Yoshimura Noh, Akinobu Minagawa, et al.
Thyroid : Official Journal of the American Thyroid Association|April 22, 2021
Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease?Nami Suzuki, Jaeduk Yoshimura Noh, Ran Yoshimura, et al.
Thyroid : Official Journal of the American Thyroid Association|July 30, 2015
Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in JapanAi Yoshihara, Jaeduk Yoshimura Noh, Natsuko Watanabe, et al.
Endocrine Journal|March 20, 2020
Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' diseaseNami Suzuki, Jaeduk Yoshimura Noh, Chiho Sugisawa, et al.
Endocrine Journal|July 11, 2014
Changes in pediatric thyroid sonograms in or nearby the Kanto region before and after the accident at the Fukushima Daiichi nuclear power plantKenji Iwaku, Jaeduk Yoshimura Noh, Eiji Sasaki, et al.
Thyroid : Official Journal of the American Thyroid Association|January 21, 2023
Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until DeliveryAi Yoshihara, Jaeduk Yoshimura Noh, Kosuke Inoue, et al.
Endocrine Journal|September 8, 2016
The characteristics of osteoporotic patients in Graves' disease patients newly diagnosed after menopause: a prospective observational studyAi Yoshihara, Jaeduk Yoshimura Noh, Koji Mukasa, et al.
Journal of the Endocrine Society|December 22, 2021
Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 PandemicKosuke Inoue, Jaeduk Yoshimura Noh, Ai Yoshihara, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Thyroid : Official Journal of the American Thyroid Association|October 2, 2019
Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in JapanNami Suzuki, Jaeduk Yoshimura Noh, Marino Hiruma, et al.
Thyroid : Official Journal of the American Thyroid Association|November 15, 2018
Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine TherapyAi Yoshihara, Kenji Iwaku, Jaeduk Yoshimura Noh, et al.
Endocrine Journal|April 9, 2013
Determination of pediatric reference levels of FT3, FT4 and TSH measured with ECLusys kitsKenji Iwaku, Jaeduk Yoshimura Noh, Akinobu Minagawa, et al.
Thyroid : Official Journal of the American Thyroid Association|April 22, 2021
Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease?Nami Suzuki, Jaeduk Yoshimura Noh, Ran Yoshimura, et al.
Thyroid : Official Journal of the American Thyroid Association|July 30, 2015
Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in JapanAi Yoshihara, Jaeduk Yoshimura Noh, Natsuko Watanabe, et al.
Endocrine Journal|March 20, 2020
Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' diseaseNami Suzuki, Jaeduk Yoshimura Noh, Chiho Sugisawa, et al.
Endocrine Journal|July 11, 2014
Changes in pediatric thyroid sonograms in or nearby the Kanto region before and after the accident at the Fukushima Daiichi nuclear power plantKenji Iwaku, Jaeduk Yoshimura Noh, Eiji Sasaki, et al.
Thyroid : Official Journal of the American Thyroid Association|January 21, 2023
Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until DeliveryAi Yoshihara, Jaeduk Yoshimura Noh, Kosuke Inoue, et al.
Endocrine Journal|September 8, 2016
The characteristics of osteoporotic patients in Graves' disease patients newly diagnosed after menopause: a prospective observational studyAi Yoshihara, Jaeduk Yoshimura Noh, Koji Mukasa, et al.
Journal of the Endocrine Society|December 22, 2021
Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 PandemicKosuke Inoue, Jaeduk Yoshimura Noh, Ai Yoshihara, et al.
Pageof 10